Swiss National Bank Bio Xcel Therapeutics, Inc. Transaction History

Swiss National Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$6.39 - $28.58 $12,141 - $54,302	1,900 Added 4.49%	44,200 $294,000
Q1 2023 May 10, 2023	SELL	$17.7 - $33.24 $70,800 - $132,960	-4,000 Reduced 8.64%	42,300 $789,000
Q1 2022 May 09, 2022	BUY	$15.0 - $22.83 $58,500 - $89,037	3,900 Added 9.2%	46,300 $968,000
Q2 2021 Aug 06, 2021	BUY	$29.06 - $38.83 $261,540 - $349,470	9,000 Added 26.95%	42,400 $1.23 Million
Q1 2021 May 07, 2021	BUY	$39.04 - $64.6 $121,024 - $200,259	3,100 Added 10.23%	33,400 $1.44 Million
Q4 2020 Feb 05, 2021	SELL	$42.46 - $56.58 $140,118 - $186,714	-3,300 Reduced 9.82%	30,300 $1.4 Million
Q3 2020 Nov 09, 2020	BUY	$37.44 - $64.63 $411,840 - $710,930	11,000 Added 48.67%	33,600 $1.46 Million
Q2 2020 Aug 05, 2020	BUY	$17.62 - $58.71 $398,212 - $1.33 Million	22,600 New	22,600 $1.2 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.